Anthem (NYSE:ANTM – Get Rating) updated its FY 2022 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $28.40- for the period, compared to the consensus estimate of $28.63. The company issued revenue guidance of -.
A number of equities analysts recently weighed in on ANTM shares. BMO Capital Markets raised their price objective on Anthem from $540.00 to $625.00 and gave the company an outperform rating in a report on Monday, April 25th. Credit Suisse Group raised their price objective on Anthem from $518.00 to $584.00 and gave the company an outperform rating in a report on Thursday, April 21st. SVB Leerink raised their price objective on Anthem from $483.00 to $555.00 and gave the company a market perform rating in a report on Thursday, April 21st. Mizuho raised their price objective on Anthem from $510.00 to $545.00 in a report on Wednesday, May 4th. Finally, Jefferies Financial Group raised their price objective on Anthem from $575.00 to $625.00 in a report on Thursday, April 21st. Three investment analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of Moderate Buy and an average price target of $550.05.
NYSE ANTM opened at $465.75 on Thursday. The company has a quick ratio of 1.36, a current ratio of 1.36 and a debt-to-equity ratio of 0.55. Anthem has a twelve month low of $355.43 and a twelve month high of $533.68. The firm has a market capitalization of $112.29 billion, a PE ratio of 18.34, a P/E/G ratio of 1.30 and a beta of 0.97. The stock’s 50 day moving average is $494.59 and its 200 day moving average is $471.25.
The firm also recently declared a quarterly dividend, which will be paid on Friday, June 24th. Stockholders of record on Friday, June 10th will be issued a dividend of $1.28 per share. This is an increase from Anthem’s previous quarterly dividend of $1.13. This represents a $5.12 dividend on an annualized basis and a dividend yield of 1.10%. The ex-dividend date of this dividend is Thursday, June 9th. Anthem’s dividend payout ratio is presently 20.16%.
In other Anthem news, Director Robert L. Dixon, Jr. sold 420 shares of the stock in a transaction dated Monday, June 6th. The stock was sold at an average price of $497.14, for a total value of $208,798.80. Following the transaction, the director now owns 9,491 shares of the company’s stock, valued at $4,718,355.74. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Ramiro G. Peru sold 990 shares of the stock in a transaction dated Thursday, May 19th. The shares were sold at an average price of $468.88, for a total value of $464,191.20. Following the completion of the transaction, the director now directly owns 9,405 shares in the company, valued at approximately $4,409,816.40. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 7,738 shares of company stock worth $3,764,851. Corporate insiders own 0.28% of the company’s stock.
Hedge funds have recently bought and sold shares of the business. Covestor Ltd increased its position in Anthem by 72.5% in the first quarter. Covestor Ltd now owns 307 shares of the company’s stock worth $151,000 after buying an additional 129 shares in the last quarter. International Assets Investment Management LLC purchased a new stake in Anthem in the first quarter worth about $213,000. Engineers Gate Manager LP purchased a new stake in Anthem in the first quarter worth about $220,000. EHP Funds Inc. purchased a new stake in Anthem in the first quarter worth about $246,000. Finally, Moors & Cabot Inc. purchased a new stake in Anthem in the first quarter worth about $251,000. 84.28% of the stock is currently owned by institutional investors.
About Anthem (Get Rating)
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small groups, individuals, Medicaid, and Medicare markets.
- Get a free copy of the StockNews.com research report on Anthem (ANTM)
- Downturn Gives These 3 Buys Juicy Dividend Yields
- Victoria’s Secret Stock is Out of the Box
- Time For a Ride in Six Flags Stock
- Why Dollar General (NYSE: DG) Should Be In Your Portfolio
- Korn Ferry Is A Good Buy For The Recession And Beyond
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.